Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood-brain barrier

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Toborek, Michal ^a   Seelbach, Melissa J ^b   Rashid, Cetewayo S ^c   András, Ibolya E ^a   Chen, Lei ^d   Park, Minseon ^a   Esser, Karyn A ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain; Drug abuse; Exercise; Methamphetamine; Oxidative stress; Tight junctions

Indexed keywords

METHAMPHETAMINE; MITOCHONDRIAL PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; CENTRAL STIMULANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CAVEOLA; CONTROLLED STUDY; EXERCISE; MALE; MICROVASCULATURE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BRAIN; DRUG EFFECTS; PHYSIOLOGY; VASCULARIZATION;

MUS;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; METHAMPHETAMINE; MICE; MICROVESSELS; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL;

EID: 84879238601     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-22     Document Type: Article

References (49)

1. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (February 7, 2008), The DASIS Report: Primary Methamphetamine/Amphetamine Admissions to Substance Abuse Treatment Rockville, MD: Drug and Alcohol Services Information System: The DASIS report. Primary methamphetamine/amphetamine admissions to substance abuse treatment 2005 http://www.oas.samhsa.gov/2k8/methamphetamineTX/meth.pdf
2. Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health, Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658 Rockville, MD: Substance Abuse and Mental Health Services Administration 2011 National survey on drug use and health. http://www.samhsa.gov
3. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Lee NK, Rawson RA, Drug Alcohol Rev 2008 27 309 317 10.1080/09595230801919494 18368613
4. Decreased cerebral blood flow of the right anterior cingulated cortex in long-term and short-term abstinent methamphetamine users. Hwang J, Lyoo IK, Kim SJ, Sung YH, Bae S, Cho SN, Lee HY, Lee DS, Renshaw PF, Drug Alcohol Depend 2006 82 177 181 10.1016/j.drugalcdep.2005.09.011 16253441
5. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. Northrop NA, Yamamoto BK, J Neuroimmune Pharmacology 2012 7 951 968 10.1007/s11481-012-9391-y
6. Methamphetamine-induced vascular changes lead to striatal hypoxia and dopamine reduction. Kousik SM, Graves SM, Napier TC, Zhao C, Carvey PM, Neuroreport 2011 22 923 928 10.1097/WNR.0b013e32834d0bc8 21979424
7. Methamphetamine toxicity and its implications during HIV-1 infection. Silverstein PS, Shah A, Gupte R, Liu X, Piepho RW, Kumar S, Kumar A, J Neurovirol 2011 17 401 415 10.1007/s13365-011-0043-4 21786077
8. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: An experimental study using light and electron microscopy. Sharma HS, Kiyatkin EA, J Chem Neuroanat 2009 37 18 32 10.1016/j.jchemneu.2008.08.002 18773954
9. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. Ramirez SH, Potula R, Fan S, Eidem T, Papugani A, Reichenbach N, Dykstra H, Weksler BB, Romero IA, Couraud PO, Persidsky Y, J Cereb Blood Flow Metab 2009 29 1933 1945 10.1038/jcbfm.2009.112 19654589
10. Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae. Park M, Hennig B, Toborek M, J Cell Mol Med 2012 16 362 375 10.1111/j.1582-4934.2011.01320.x 21435178
11. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier. Bowyer JF, Thomas M, Schmued LC, Ali SF, Ann NY Acad Sci 2008 1139 127 139 10.1196/annals.1432.005 18991857
12. Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo. Moszczynska A, Yamamoto BK, J Neurochem 2011 116 1005 1017 10.1111/j.1471-4159.2010.07147.x 21166679
13. American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP, Med Sci Sports Exerc 2011 43 1334 1359 10.1249/MSS. 0b013e318213fefb 21694556
14. Exercise training improves low-density lipoprotein oxidability in untrained subjects with coronary artery disease. Ziegler S, Schaller G, Mittermayer F, Pleiner J, Mihaly J, Niessner A, Richter B, Steiner-Boeker S, Penak M, Strasser B, Wolzt M, Arch Phys Med Rehabil 2006 87 265 269 10.1016/j.apmr.2005.09.025 16442983 (Pubitemid 43151304)
15. Antioxidants and physical performance in elderly persons: the invecchiare in Chianti (InCHIANTI) study. Cesari M, Pahor M, Bartali B, Cherubini A, Penninx BW, Williams GR, Atkinson H, Martin A, Guralnik JM, Ferrucci L, Am J Clin Nutr 2004 79 289 294 14749236 (Pubitemid 41095983)
16. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA, Nat Rev Immunol 2011 11 607 615 10.1038/nri3041 21818123
17. Running is rewarding and antidepressive. Brené S, Bjørnebekk A, Aberg E, Mathé AA, Olson L, Werme M, Physiol Behav 2007 92 136 140 10.1016/j.physbeh.2007.05.015 17561174 (Pubitemid 47374234)
18. A multihealth behavior intervention integrating physical activity and substance use prevention for adolescents. Werch CC, Moore MJ, DiClemente CC, Bledsoe R, Jobli E, Prev Sci 2005 6 213 226 10.1007/s11121-005-0012-3 16133900 (Pubitemid 43487955)
19. Acute exercise modulates cigarette cravings and brain activation in response to smoking-related images: an fMRI study. Janse Van Rensburg K, Taylor A, Hodgson T, Benattayallah A, Psychopharmacology 2009 203 589 598 10.1007/s00213-008-1405-3 19015835
20. Methamphetamine self-administration and voluntary exercise have opposing effects on medial prefrontal cortex gliogenesis. Mandyam CD, Wee S, Eisch AJ, Richardson HN, Koob GF, J Neurosci 2007 27 11442 11450 10.1523/JNEUROSCI.2505- 07.2007 17942739 (Pubitemid 47621323)
21. Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities. Chiurchiù V, Maccarrone M, Antioxid Redox Signal 2011 15 2605 2641 10.1089/ars.2010.3547 21391902
22. Brain antioxidant systems in human methamphetamine users. Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Sherwin A, Nobrega JN, Forman HJ, Kish SJ, J Neurochem 2004 89 1396 1408 10.1111/j.1471-4159.2004.02434.x 15189342 (Pubitemid 38802661)
23. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ, J Pharmacol Exp Ther 2006 319 703 709 10.1124/jpet.106.109173 16857724
24. Methamphetamine causes mitrochondrial oxidative damage in human T lymphocytes leading to functional impairment. Potula R, Hawkins BJ, Cenna JM, Fan S, Dykstra H, Ramirez SH, Morsey B, Brodie MR, Persidsky Y, J Immunol 2010 185 2867 2876 10.4049/jimmunol.0903691 20668216
25. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase. Maragos WF, Jakel R, Chesnut D, Pocernich CB, Butterfield DA, St Clair D, Cass WA, Brain Res 2000 878 218 222 10.1016/S0006-8993(00)02707-4 10996156
26. Methamphetamine toxicity and messengers of death. Krasnova IN, Cadet JL, Brain Res Rev 2009 60 379 407 10.1016/j.brainresrev.2009.03.002 19328213
27. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Ushio-Fukai M, Antioxid Redox Signal 2009 11 1289 1299 10.1089/ars.2008. 2333 18999986
28. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG, Cell 2005 122 221 233 10.1016/j.cell.2005.05.011 16051147 (Pubitemid 41032986)
29. Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. Brown JE, Zeiger SL, Hettinger JC, Brooks JD, Holt B, Morrow JD, Musiek ES, Milne G, McLaughlin B, J Neurosci 2010 30 5242 5252 10.1523/JNEUROSCI.6366-09.2010 20392947
30. Role of glutathione redox cycle in TNF-alpha-mediated endothelial cell dysfunction. Toborek M, Barger SW, Mattson MP, McClain CJ, Hennig B, Atherosclerosis 1995 117 179 188 10.1016/0021-9150(95)05568-H 8801863
31. Molecular mechanisms of natural products in chemoprevention: induction of cytoprotective enzymes by Nrf2. Eggler AL, Gay KA, Mesecar AD, Mol Nutr Food Res 2008 52 Suppl 1 84 S94 18435489
32. A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders. Kim J, Cha YN, Surh YJ, Mutat Res 2010 690 12 23 10.1016/j.mrfmmm.2009.09.007 19799917
33. The blood-brain barrier in health and chronic neurodegenerative disorders. Zlokovic BV, Neuron 2008 57 178 201 10.1016/j.neuron.2008.01.003 18215617
34. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Toborek M, Lee YW, Flora G, Pu H, András IE, Wylegala E, Hennig B, Nath A, Cell Mol Neurobiol 2005 25 181 199 10.1007/s10571-004-1383-x 15962513 (Pubitemid 40558590)
35. The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Paolinelli R, Corada M, Orsenigo F, Dejana E, Pharmacol Res 2011 63 165 171 10.1016/j.phrs.2010.11.012 21167284
36. Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Kiyatkin EA, Brown PL, Sharma HS, Eur J Neurosci 2007 26 1242 1253 10.1111/j.1460-9568.2007. 05741.x 17767502 (Pubitemid 47346759)
37. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E, Am J Pathol 2007 170 1389 1397 10.2353/ajpath.2007.060693 17392177 (Pubitemid 47339345)
38. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S, J Cell Biol 2003 161 653 660 10.1083/jcb.200302070 12743111 (Pubitemid 36578587)
39. HIV-1 Tat triggers nuclear localization of ZO-1 via Rho signaling and cAMP response element-binding protein activation. Zhong Y, Zhang B, Eum SY, Toborek M, J Neurosci 2012 32 143 150 10.1523/JNEUROSCI.4266-11.2012 22219277
40. Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. Zhong Y, Smart EJ, Weksler B, Couraud PO, Hennig B, Toborek M, J Neurosci 2008 28 7788 7796 10.1523/JNEUROSCI.0061-08.2008 18667611
41. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Yamamoto M, Ramirez SH, Sato S, Kiyota T, Cerny RL, Kaibuchi K, Persidsky Y, Ikezu T, Am J Pathol 2008 172 521 533 10.2353/ajpath.2008.070076 18187566 (Pubitemid 351282037)
42. Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Persidsky Y, Heilman D, Haorah J, Zelivyanskaya M, Persidsky R, Weber GA, Shimokawa H, Kaibuchi K, Ikezu T, Blood 2006 107 4770 4780 10.1182/blood-2005-11-4721 16478881 (Pubitemid 43882628)
43. Rho and Rac but not Cdc42 regulate endothelial cell permeability. Wojciak-Stothard B, Potempa S, Eichholtz T, Ridley AJ, J Cell Sci 2001 114 1343 1355 11257000 (Pubitemid 32409470)
44. Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y, Psychopharmacology 2005 178 296 302 10.1007/s00213-004-1998-0 15452681 (Pubitemid 40379224)
45. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Melega WP, Cho AK, Harvey D, Laćan G, Synapse 2007 61 216 220 10.1002/syn.20365 17230548
46. Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. Seelbach MJ, Brooks TA, Egleton RD, Davis TP, J Neurochem 2007 102 1677 1690 10.1111/j.1471-4159.2007.04644.x 17697052 (Pubitemid 47256196)
47. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Williams IA, Allen DG, Am J Physiol Heart Circ Physiol 2007 293 1969 H1977 10.1152/ajpheart.00489.2007 17573457 (Pubitemid 47367249)
48. Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. Sun X, Shih AY, Johannssen HC, Erb H, Li P, Murphy TH, J Biol Chem 2006 281 17420 17431 10.1074/jbc.M601567200 16624809
49. Vessel micro port technique for applications in cerebrovascular research. Chen L, Swartz KR, Toborek M, J Neurosci Res 2009 87 1718 1727 10.1002/jnr.21973 19115415